Division of Pediatric Urology, Morgan Stanley Children's Hospital of New York-Presbyterian, Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
J Urol. 2013 Sep;190(3):1028-32. doi: 10.1016/j.juro.2013.03.005. Epub 2013 Mar 6.
There is a known association between nonneurogenic lower urinary tract conditions and vesicoureteral reflux. Whether reflux is secondary to the lower urinary tract condition or coincidental is controversial. We determined the rate of reflux resolution in patients with lower urinary tract dysfunction using targeted treatment for the underlying condition.
Patients diagnosed and treated for a lower urinary tract condition who had concomitant vesicoureteral reflux at or near the time of diagnosis were included. Patients underwent targeted treatment and antibiotic prophylaxis, and reflux was monitored with voiding cystourethrography or videourodynamics.
Vesicoureteral reflux was identified in 58 ureters in 36 females and 5 males with a mean age of 6.2 years. After a mean of 3.1 years of treatment reflux resolved with targeted treatment in 26 of 58 ureters (45%). All of these patients had a history of urinary tract infections before starting targeted treatment. Resolution rates of vesicoureteral reflux were similar for all reflux grades. Resolution or significant improvement of reflux was greater in the ureters of patients with dysfunctional voiding (70%) compared to those with idiopathic detrusor overactivity disorder (38%) or detrusor underutilization (40%).
Vesicoureteral reflux associated with lower urinary tract conditions resolved with targeted treatment and antibiotic prophylaxis in 45% of ureters. Unlike the resolution rates reported in patients with reflux without a coexisting lower urinary tract condition, we found that there were no differences in resolution rates among grades I to V reflux in patients with lower urinary tract conditions. Patients with dysfunctional voiding had the most improvement and greatest resolution of reflux. Additionally grade V reflux resolved in some patients.
已知非神经源性下尿路疾病与膀胱输尿管反流之间存在关联。反流是继发于下尿路疾病还是巧合存在存在争议。我们通过针对潜在疾病的靶向治疗来确定下尿路功能障碍患者的反流缓解率。
本研究纳入了在诊断时或临近诊断时患有下尿路疾病且伴有膀胱输尿管反流的患者。患者接受了靶向治疗和抗生素预防,并通过排尿性膀胱尿道造影或视频尿动力学检查监测反流情况。
36 名女性和 5 名男性共 58 侧输尿管存在膀胱输尿管反流,平均年龄为 6.2 岁。经过平均 3.1 年的治疗,在 58 侧输尿管中有 26 侧(45%)通过靶向治疗使反流得到缓解。所有这些患者在开始靶向治疗前均有尿路感染史。所有反流分级的反流缓解率相似。在有排尿功能障碍的患者中,反流的缓解或显著改善率(70%)高于特发性逼尿肌过度活动症(38%)或逼尿肌低顺应性(40%)患者。
通过靶向治疗和抗生素预防,45%的下尿路疾病相关膀胱输尿管反流得到缓解。与无并存下尿路疾病患者的反流缓解率不同,我们发现下尿路疾病患者的反流分级 I 至 V 之间的缓解率无差异。排尿功能障碍患者的反流改善最大,缓解率最高。此外,一些患者的反流分级 V 也得到了缓解。